Earnings Call for Q4FY22 of Rossari Biotech
Conference Call with Rossari Biotech Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.23-05-2022
23-05-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Publication of Extracts of Consolidated Audited Financial Results for the Quarter and Financial Year ended March 31, 202221-05-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Updates20-05-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation of Press Release titled " Rossari Biotech announces Q4 & FY22 results"20-05-2022
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Investor Presentation
Intimation of Q4 & FY22 Earnings Presentation20-05-2022
Rossari Biotech Ltd - 543213 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year 2021-2220-05-2022
Rossari Biotech Ltd - 543213 - Board recommends Final Dividend
Rossari Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, have approved the following: - Final Dividend of 25% (i.e. Re. 0.50/- per share) on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2022, subject to approval of the Shareholders at the forthcoming Annual General Meeting ("AGM") of the Company.20-05-2022
Rossari Biotech Ltd - 543213 - Intimation Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Contact details of Key Managerial Personnel who are severally authorised to determine materiality of an event or information and make disclosures to Stock Exchange pursuant to Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.19-05-2022
Rossari Biotech Ltd - 543213 - Outcome Of Board Meeting Held On Thursday, May 19, 2022
The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the Financial Year 2021-22 and other matters.19-05-2022